Top compounds associated with response to LMBRD1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib FIMM pan-cancer AAC -0.38 0.02
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.078 0.02
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.079 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA simvastatin CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.16 0.02
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.074 0.02
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.11 0.03
Download CSV